Tom Whelan

Tom focuses his practice on private equity and M&A, advising private equity sponsors, multi-strategy funds, other private capital investors, and corporates, helping them deploy capital across the world.

Experience

Representative matters

Advised H2 Equity Partners on the acquisition of William Hackett Holdings Limited (advised on prior to joining Reed Smith)

Advised Investcorp on three separate tech-related investments (advised on prior to joining Reed Smith)

Advised SilverTree Equity on two simultaneous investments: their co-control investment with Kantar to acquire Step-Up RGM; and their co-control investment in XTEL, alongside Kantar Group (a Bain Capital portfolio company) (advised on prior to joining Reed Smith)

Experience

Advised H2 Equity Partners on the acquisition of William Hackett Holdings Limited (advised on prior to joining Reed Smith)

Advised Investcorp on three separate tech-related investments (advised on prior to joining Reed Smith)

Advised HIG Capital on multiple deals (advised on prior to joining Reed Smith)

Advised EIH Capital Partners on the sale of The Expanded Metal Company to Meiser International GmbH (advised on prior to joining Reed Smith)

Advised Capital D on its proposed acquisition of a tech business (advised on prior to joining Reed Smith)

Acted for the senior management of Unilabs on their sale of their equity in Unilabs AB and their equity reinvestment (advised on prior to joining Reed Smith)

Advised the senior management of Covis Pharma on the sale and rollover to a new Apollo vehicle, and subsequent MIP restructuring (advised on prior to joining Reed Smith)

Advised Pritzker Private Equity/Vertellus on the acquisition of Polyscope Holdings B.V (advised on prior to joining Reed Smith)

Advised Eight Roads on the sale of Optegra to H2 Equity Partners (advised on prior to joining Reed Smith)

Advised Management on sale of Facile.it to Silverlake and new MIP (advised on prior to joining Reed Smith)

Advised Aksiom and Ara Partners in connection with the acquisition of PX group (advised on prior to joining Reed Smith)

Advised UK Management of Group Winncare on the sale of their equity to Siparex (advised on prior to joining Reed Smith)

Advised IDI on its buyout of Mangar Health (advised on prior to joining Reed Smith)

Advised Fortress on the acquisition of Majestic Wines (advised on prior to joining Reed Smith)

Advising a PE House on two potential Take Privates (advised on prior to joining Reed Smith)

Advised 2 Founders on a joint bid for an AIM listed company with a PE house (advised on prior to joining Reed Smith)

Recognitions

Ranked in Chambers UK for UK-wide Private Equity: Buyouts: Up to £500 million, 2022-2026
Listed as a Leading Partner in The Legal 500 UK for Private Equity: Transactions - Mid-Market Deals (up to £500m), 2025-2027
Listed as Highly Regarded in IFLR1000 Global for United Kingdom Private Equity, 2022-2025